SureTrader
Interactive Brokers Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 11/20/2017 12:28:57 PM - Followers: 1365 - Board type: Free - Posts Today: 20

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
FDA Calendar
Recent Biotech Buyouts

Buyouts of Biotech Partners
Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

SureTrader
Interactive Brokers Advertisement
PostSubject
#215327  Sticky Note DCPH > up 5% on Phase I interim data... biocqr 11/20/17 11:26:38 AM
#215324  Sticky Note ENTA—Mavyret US scripts—week ending 11/10/17 (according to IMS)…. DewDiligence 11/20/17 10:56:40 AM
#215315  Sticky Note Roche reports PFS from phase-3 in first-line non-squamous NSCLC: DewDiligence 11/20/17 10:13:50 AM
#215314  Sticky Note Roche Cancer Drug Rises To Challenge Merck, Bristol-Myers http://www.forbes.com/ Titan V 11/20/17 10:08:43 AM
#215259  Sticky Note Re: ADXS assessment …what is your take on DewDiligence 11/17/17 02:29:59 PM
#213801  Sticky Note Re: Buying in advance of phase-3 DewDiligence 09/23/17 02:15:40 PM
#215332   Great article from Seeking Alpha. Is PKTX The Next Brando1975 11/20/17 12:28:56 PM
#215331   Thats ok. Just feel it's an incredible Brando1975 11/20/17 12:21:52 PM
#215330   Sorry, i read too fast, thought you meant rkrw 11/20/17 11:38:54 AM
#215329   You better look harder my friend. Ceo Brando1975 11/20/17 11:35:11 AM
#215328   PRTK proxy shows all management combined hold 4.9%. rkrw 11/20/17 11:33:24 AM
#215327   DCPH > up 5% on Phase I interim data... biocqr 11/20/17 11:26:38 AM
#215326   OMHE_Developed_Cannabinoid_Based_Pain_Treatment_Therapy goodibag 11/20/17 11:14:26 AM
#215325   PKTX... Huge insider buying and Ceo Brando1975 11/20/17 10:59:17 AM
#215324   ENTA—Mavyret US scripts—week ending 11/10/17 (according to IMS)…. DewDiligence 11/20/17 10:56:40 AM
#215323   BHVN PR on pediatric migraine trial plan: DewDiligence 11/20/17 10:50:38 AM
#215322   Please maintain thread integrity! Your post about VVUS DewDiligence 11/20/17 10:45:33 AM
#215321   NVGN—>KZIA effective 11/24/17: DewDiligence 11/20/17 10:43:41 AM
#215320   $VVUS has 251.52M CASH! MazelTov 11/20/17 10:43:06 AM
#215319   I was thinking more about Avastin's side effects DewDiligence 11/20/17 10:42:50 AM
#215318   combination of TECENTRIQ…and Avastin…plus chemotherapy (paclitaxel and ca jbog 11/20/17 10:40:18 AM
#215317   Speaking of PBMD…it’s new name is Immutep Ltd: DewDiligence 11/20/17 10:36:50 AM
#215316   ACOR’s termination of Tozadenant program is anticlimactic after DewDiligence 11/20/17 10:29:48 AM
#215315   Roche reports PFS from phase-3 in first-line non-squamous NSCLC: DewDiligence 11/20/17 10:13:50 AM
#215314   Roche Cancer Drug Rises To Challenge Merck, Bristol-Myers http://www.forbes.com/ Titan V 11/20/17 10:08:43 AM
#215313   We owned pure-breed, AKC-registered, Pekingese, Shetland Sheep, back north40000 11/20/17 09:24:58 AM
#215312   Good to know. I think if P3 kris_kade 11/19/17 09:00:01 PM
#215311   NVS/(REGN)—Addendum to #msg-136172038: Unlike the FDA, the EMA DewDiligence 11/19/17 06:23:24 PM
#215310   BTW, all commercial botulinum-toxin products of consequence are DewDiligence 11/19/17 04:46:27 PM
#215309   PBMD has a LAG-3 agonist antibody for autoimmune DewDiligence 11/19/17 04:28:52 PM
#215308   >>Ownership of a mixed-breed dog was associated with biomaven0 11/19/17 04:04:40 PM
#215307   Re Biowatch loparn 11/19/17 03:07:06 PM
#215306   Ownership of a mixed-breed dog was associated with Biowatch 11/19/17 03:00:35 PM
#215305   Agree, you must be healthy enough to walk dog Biowatch 11/19/17 02:44:32 PM
#215304   ZIOP from SNO 2017. News on the 1st abstract buckiii2 11/19/17 02:31:47 PM
#215303   Re quiz loparn 11/19/17 02:20:52 PM
#215302   >>If you're dead or lazy, you don't report biomaven0 11/19/17 01:43:15 PM
#215301   >>select antibodies with TREM2 agonist activity biomaven0 11/19/17 01:40:39 PM
#215300   Although Botox and RT002 both have type-A botulinum DewDiligence 11/19/17 01:35:08 PM
#215298   DNLI (TREM2) - Of the targets you mention mcbio 11/19/17 01:02:20 PM
#215296   "AdaptVac reaches proof of concept in animals for loparn 11/19/17 12:28:22 PM
#215295   Not necessarily. Botox and Botox cosmetic from AGN kris_kade 11/19/17 09:37:29 AM
#215294   RVNC- “In any event, daxibotulinumtoxinA is now the biotech_researcher 11/19/17 08:56:09 AM
#215293   Self-reported health and lifestyle habits were available for Bickema 11/18/17 11:43:01 PM
#215292   >>Reverse causality? One needs to be in good biomaven0 11/18/17 11:14:16 PM
#215291   Re: quiz- ciotera 11/18/17 06:11:34 PM
#215290   Current consensus is targeted RIPK1 would be enough. biomaven0 11/18/17 06:11:05 PM
#215289   Necroptosis is an alternative cell death pathway different mcbio 11/18/17 05:27:51 PM
#215288   >>Are RIP1 and RIPK1 one and the same? biomaven0 11/18/17 05:15:04 PM
#215287   DNLI - Blocking RIPK1 likely prevent necroptosis of mcbio 11/18/17 05:08:14 PM
#215286   (OT quiz) biomaven0 11/18/17 04:10:56 PM
#215285   Re: CHRS /AMGN’s new Enbrel injector DewDiligence 11/18/17 12:20:01 PM
#215284   Isn't it…that the RVNC molecule is not the DewDiligence 11/18/17 12:02:49 PM
#215283   Top 40 Drugs in the Pipeline—Sep 2016 Titan V 11/18/17 11:04:51 AM
#215282   BMRN / Rare diseases ghmm 11/18/17 10:36:19 AM
#215281   Re: RVNC /FDA ODD in cervical dystonia shareholder_boar 11/18/17 02:10:43 AM
PostSubject